-
Company Profile
Oxurion NV – Company Profile
Oxurion NV (Oxurion), formerly ThromboGenics NV, is a biotechnology company, which develops and commercializes ophthalmic and cancer therapeutics. The company’s ocriplasmin, a recombinant derivative of the plasmin protein, is commercialized as Jetrea in the US to treat symptomatic vitreomacular adhesion (VMA) and vitreomacular traction (VMT). Oxurion’s product pipeline includes THR-687, a pan-RGD integrin antagonist being developed for the treatment of diabetic retinopathy, and THR-149, a plasma kallikrein inhibitor, for the treatment of diabetic macular edema (DME). It has commercialization agreements...
Add to Basket -
Sector Analysis
Peru Baby Food Market Size by Categories, Distribution Channel, Market Share and Forecast, 2022-2027
Peru Baby Food Market Report Overview The Peru baby food market size was valued at PEH877.1 million ($226 million) in 2021 and is expected to achieve a CAGR of less than 2% during 2021-2027. Baby milks dominated the Peruvian baby food sector and Nestlé remained the overall market leader in 2021. The Peru baby food market research report provides extensive and highly detailed current and future market trends in the Peru market. Peru Baby Food Market Outlook For more insights on...
-
Sector Analysis
China Baby Food Market Size by Categories, Distribution Channel, Market Share and Forecast, 2022-2027
China baby food market size was $12.24 billion in the year 2021. The market is expected to grow at a CAGR of more than 7% during the period 2021-2027. China baby food market research report provides consumption data based upon a unique combination of industry research, fieldwork, market sizing work and our in-house expertise to offer extensive data about the trends and dynamics affecting the industry.
-
Sector Analysis
Turkey Baby Food, 2021
The baby food market in Turkey was valued at $215.3 million in 2020 and is forecasted to register a growth of more than 15% during the period 2021-2026. In 2019, both per capita expenditure and consumption on baby food in Turkey was lower than the global and regional levels. Baby milks accounted for the highest share of the overall baby food sector in value terms, in 2020, followed by baby cereals and dry meals, baby wet meals, baby finger foods,...
-
Sector Analysis
Australia Baby Food, 2021 Update – Market Size by Categories, Consumer Behaviour, Trends and Forecast to 2026
“Australia Baby Food, 2021 Update” is an analytical report by GlobalData which provides extensive and highly detailed current and future market trends in the Australian market. The total number of live births in Australia recorded a marginal 1.5% decrease during 2014-2020. However, the forecast increment in number of live births over 2020-2026 translates into a bigger total addressable market for baby foods. The baby food sector recorded a value CAGR of 1.96% during 2014-2020. There has been little change in...
-
Track & Monitor
Partnerships, Licensing, Investments and M&A Deals and Trends for February 2017 in Pharmaceuticals
The pharmaceutical and healthcare industry reported a decrease in the number of deals and deal values in February 2017. The industry reported 302 deals worth USD19.4 billion in February 2017, compared to 342 deals worth USD57.4 billion in January 2017. The oncology therapeutics market remained at the top in deal activity in February 2017 with 117 deals. In second place, central nervous system therapeutics market reported 60 deals. Licensing agreements in pharmaceutical and healthcare industry registered a decrease in upfront...
-
Product Insights
Asthma Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Asthma Global Clinical Trials Review, H1, 2017" provides an overview of Asthma clinical trials scenario. This report provides top line data relating to the clinical trials on Asthma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Anthrax Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Anthrax Global Clinical Trials Review, H1, 2017" provides an overview of Anthrax clinical trials scenario. This report provides top line data relating to the clinical trials on Anthrax. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Arterial Thrombosis Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Arterial Thrombosis Global Clinical Trials Review, H1, 2017" provides an overview of Arterial Thrombosis clinical trials scenario. This report provides top line data relating to the clinical trials on Arterial Thrombosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Asperger Syndrome Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Asperger Syndrome Global Clinical Trials Review, H1, 2017" provides an overview of Asperger Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Asperger Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Allergic Asthma Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Allergic Asthma Global Clinical Trials Review, H1, 2017" provides an overview of Allergic Asthma clinical trials scenario. This report provides top line data relating to the clinical trials on Allergic Asthma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Acquired (Autoimmune) Hemolytic Anemia Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Acquired (Autoimmune) Hemolytic Anemia Global Clinical Trials Review, H1, 2017" provides an overview of Acquired (Autoimmune) Hemolytic Anemia clinical trials scenario. This report provides top line data relating to the clinical trials on Acquired (Autoimmune) Hemolytic Anemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Cachexia Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Cachexia Global Clinical Trials Review, H1, 2017" provides an overview of Cachexia clinical trials scenario. This report provides top line data relating to the clinical trials on Cachexia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Opioid-Induced Constipation (OIC) Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Opioid-Induced Constipation (OIC) Global Clinical Trials Review, H2, 2016" provides an overview of Opioid-Induced Constipation (OIC) clinical trials scenario. This report provides top line data relating to the clinical trials on Opioid-Induced Constipation (OIC). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Chronic Obstructive Pulmonary Disease (COPD) Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Chronic Obstructive Pulmonary Disease (COPD) Global Clinical Trials Review, H1, 2016" provides an overview of Chronic Obstructive Pulmonary Disease (COPD) clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Obstructive Pulmonary Disease (COPD). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...
-
Product Insights
Malignant Fibrous Histiocytoma Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Malignant Fibrous Histiocytoma Global Clinical Trials Review, H2, 2016" provides an overview of Malignant Fibrous Histiocytoma clinical trials scenario. This report provides top line data relating to the clinical trials on Malignant Fibrous Histiocytoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Ulcerative Colitis Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Ulcerative Colitis Global Clinical Trials Review, H2, 2016" provides an overview of Ulcerative Colitis clinical trials scenario. This report provides top line data relating to the clinical trials on Ulcerative Colitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Peripheral Neuropathic Pain Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Peripheral Neuropathic Pain Global Clinical Trials Review, H2, 2016" provides an overview of Peripheral Neuropathic Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Peripheral Neuropathic Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Arterial Thrombosis Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Arterial Thrombosis Global Clinical Trials Review, H2, 2016" provides an overview of Arterial Thrombosis clinical trials scenario. This report provides top line data relating to the clinical trials on Arterial Thrombosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Hypertrophic Cardiomyopathy Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Hypertrophic Cardiomyopathy Global Clinical Trials Review, H2, 2016" provides an overview of Hypertrophic Cardiomyopathy clinical trials scenario. This report provides top line data relating to the clinical trials on Hypertrophic Cardiomyopathy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...